Doug Hampton 
NEW YORK, June 6, 2023 /PRNewswire/ — Mend™, a life sciences and digital health company operating at the intersection of nutrapharma, food as medicine, and behavioral health, announced today it has received a round of Series A funding. The $15M round is led by S2G Ventures, a leading multi-stage investment firm dedicated to backing innovative, … Read more
Public welcome to attend open house event ST. GEORGE, Utah, June 6, 2023 /PRNewswire/ — St. George Surgical Center (SGSC) will host a public open house celebrating the grand opening of its new state-of-the-art surgical facility. The open house will be held Friday, June 16 from 10 a.m.–4 p.m. at 585 E. Riverside Drive St. George, … Read more
PLANO, Texas, 6 de junio de 2023 /PRNewswire-HISPANIC PR WIRE/ — Una función doble de Lexus el próximo 8 de junio a las 8:00 p. m. (hora del este). #LexusTX #LexusGX Manténgase atento para obtener más información y haga clic aquí para ver los avances anteriores de los Lexus GX y TX 2024. PRÓXIMAMENTE EL … Read more
Nature’s Bounty® Sleep3 Gummies Offer a New Format of the Popular Sleep3 Tablets HOBOKEN, N.J., June 6, 2023 /PRNewswire/ — Nature’s Bounty®, a Nestlé Health Science Company and a leader in scientifically-backed vitamin and nutritional supplements, is redefining what it means to achieve quality sleep with the introduction of its new Sleep3 Gummies supplement. The new … Read more
Large-Capacity Tabletop Freezer Expands Line of Controlled-Rate Freezers for Cell and Gene Therapies; Now Available for Order BOTHELL, Wash., June 6, 2023 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced … Read more
EU CTA marks second regulatory clearance for Phase 1 ANQUR clinical trial of QRL-201 in ALS ANQUR is first-ever clinical trial to evaluate a therapy that rescues STATHMIN-2 expression in ALS patients QurAlis recently announced first patient dosed in Canada; enrollment completed in Cohort 1 portion of ANQUR CAMBRIDGE, Mass., June 6, 2023 /PRNewswire/ — … Read more
INT230-6 Induced T-Cell Receptor Signaling, Macrophage Markers, and IL-18 and B-Cell Receptor Signaling Data Was Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on June 4, 2023 WESTPORT, Conn., June 6, 2023 /PRNewswire/ — Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based … Read more
Gavan introduces FaTRIXTM alternative protein-enriched fat ingredient that butters up chef pastries and slashes saturated fat by 80% ACRE, Israel, June 6, 2023 /PRNewswire/ — FoodTech start-up Gavan Technologies, Ltd. leverages its no-waste protein extraction platform to deliver FaTRIX™, a leading-edge alternative fat solution. FaTRIX offers a series of high-performance, protein-based fat substitutes that serve as … Read more
PRINCETON, N.J., June 6, 2023 /PRNewswire/ — CCRM Fertility IRMS Reproductive Medicine is excited to announce the opening of a stunning new office in Princeton, New Jersey. Conveniently located off route 1, minutes from downtown and only an hour from Philadelphia and New York City, the office is well-situated on Princeton University’s Forrestal Campus at … Read more
“We continue to evolve our portfolio with the consumer and patient top-of-mind, developing products that deliver on both current and future wants and needs,” says Lana Culley, Vice President of Product Development at Aurora Cannabis. “With the introduction of innovations like our snackable, low dose Lil’ Bits and our XL premium resin vape pens, we’re … Read more